diakron.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * | ||
Meta Tags
| Title | Diakron |
| Description | Cardiovascular company with focus on developing novel drug candidates in the area of hypertension, dyslipidemia and |
| Keywords | Diakron,Diakron Pharmaceuticals,cardiovascular,diabetes,hypertension,calcium channels,Type II diabetes,T-type calicium channels,Cholesterol,glucose,systolic blood pressure,blood pressure,insulin,hyperglycemic,HDL,LDL |
Server Information
| WebSite | |
| Host IP | 205.178.145.68 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
diakron.com Valuation
|
US$1,737
Last updated: 2023-05-11 22:27:38
diakron.com has Semrush global rank of 0. diakron.com has an estimated worth of US$ 1,737, based on its estimated Ads revenue. diakron.com receives approximately 200 unique visitors each day. Its web server is located in United States, with IP address 205.178.145.68. According to SiteAdvisor, diakron.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,737 |
| Daily Ads Revenue | US$1 |
| Monthly Ads Revenue | US$48 |
| Yearly Ads Revenue | US$577 |
| Daily Unique Visitors | 13 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| diakron.com. | A | 7199 | IP: 205.178.145.68 |
| diakron.com. | NS | 7200 | NS Record: ns12.worldnic.com. |
| diakron.com. | NS | 7200 | NS Record: ns11.worldnic.com. |
| diakron.com. | MX | 7200 | MX Record: 10 mx1.netsolmail.net. |
HtmlToTextCheckTime:2023-05-11 22:27:38
| Diakron Pharmaceuticals Home Product Summary News Contact Diakron Pharmaceuticals, Inc. is a cardiovascular drug development company focused on clinically differentiated products for significant cardiovascular markets. Diakron will complete Phase II development of DP-4088, a direct thrombin inhibitor, and complete Phase I development of a lead T-type calcium channel blocker (TCCB). Diakron develops unique products for the cardiovascular and related fields. Today, the focus, based on expected resources, is to develop products to an important clinical milestone and then to potentially partner, out-license or co-market to speed late-stage development and marketing. Given adequate resources, the Diakron Management Team is prepared to take the Diakron products through clinical development, registration and marketing. The Company currently has development programs targeting clotting disorders, hypertension, and |
HTTP Headers
HTTP/1.1 200 OK Server: openresty/1.17.8.2 Date: Wed, 17 Nov 2021 09:04:09 GMT Content-Type: text/html Content-Length: 7837 Connection: keep-alive Vary: Accept-Encoding Last-Modified: Mon, 16 Feb 2015 19:23:04 GMT ETag: "1e9d-50f3983f3b36e" X-Webcom-Cache-Status: BYPASS Accept-Ranges: bytes |
diakron.com Whois Information
Domain Name: DIAKRON.COM Registry Domain ID: 6672232_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2021-03-22T07:33:29Z Creation Date: 1999-05-21T04:35:06Z Registry Expiry Date: 2022-05-21T04:35:41Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: abuse@web.com Registrar Abuse Contact Phone: +1.8003337680 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS11.WORLDNIC.COM Name Server: NS12.WORLDNIC.COM DNSSEC: unsigned >>> Last update of whois database: 2021-11-17T08:36:09Z <<< |